Improve Concentration

Featured Article

Drugmaker Targacept Inc. says their experimental adult ADHD medication has met its primary target in a Phase II clinical trial. The drug--AZD3480--was originally developed for Alzheimer's disease, but it failed to be effective. However, researchers say 50 mg of the medication improved attention, memory problems, hyperactivity, and restlessness in a study of adults with ADHD.

Read more

More information on "Improve Concentration"

From Our Experts

See more SharePosts »

From Our Sources

More on ADHD »